6601Bronchiectasis. Incapacitating infection totaling at least six weeks a year is 100%; four to six weeks, or near-constant purulent cough with anorexia, weight loss and frank hemoptysis on almost continuous antibiotics, is 60%; two to four weeks, or daily productive cough needing four-to-six-week antibiotic courses more than twice a year, is 30%; intermittent productive cough needing antibiotics at least twice a year is 10%. Or rate on pulmonary impairment as chronic bronchitis (DC 6600). An incapacitating episode requires bed rest and treatment by a physician.10% • 30% • 60% • 100%
6817Pulmonary vascular disease. Primary pulmonary hypertension, or chronic pulmonary thromboembolism with pulmonary hypertension, right ventricular hypertrophy or cor pulmonale, is 100%; thromboembolism requiring anticoagulant therapy, or inferior vena cava surgery without pulmonary hypertension or right ventricular dysfunction, is 60%; symptomatic after a resolved embolism is 30%; asymptomatic after resolution is 0%. Other residuals of pulmonary embolism are rated under the most appropriate code, such as DC 6600 or DC 6604.0% • 30% • 60% • 100%
6819Malignant neoplasms of any specified part of the respiratory system, excluding skin growths. Respiratory cancer of any type is PACT Act presumptive. The 100% rating continues beyond the end of surgery, radiation, chemotherapy or other treatment; six months after treatment stops a mandatory VA examination sets the new evaluation, subject to § 3.105(e). If there has been no local recurrence or metastasis, you are then rated on residuals.100% during treatment
6820Benign neoplasms of any specified part of the respiratory system — evaluated using an appropriate respiratory analogy, meaning whichever formula fits the impairment the tumor leaves behind.By analogy
6846Sarcoidosis — PACT Act presumptive. Cor pulmonale, cardiac involvement with congestive heart failure, or progressive pulmonary disease with fever, night sweats and weight loss despite treatment is 100%; pulmonary involvement requiring systemic high-dose therapeutic corticosteroids is 60%; persistent symptoms requiring chronic low-dose maintenance or intermittent corticosteroids is 30%; chronic hilar adenopathy or stable infiltrates without symptoms is 0%. Or rate active disease or residuals as chronic bronchitis (DC 6600), with extra-pulmonary involvement rated under the body system involved.0% • 30% • 60% • 100%
6847Sleep apnea syndromes — obstructive, central or mixed. Chronic respiratory failure with carbon dioxide retention or cor pulmonale, or a required tracheostomy, is 100%; requiring a breathing assistance device such as a CPAP machine is 50%; persistent daytime hypersomnolence is 30%; documented sleep-disordered breathing without symptoms is 0%.0% • 30% • 50% • 100%
6730Tuberculosis, pulmonary, chronic, active. Rated 100%. Active pulmonary tuberculosis is also treated as permanently and totally disabling for non-service-connected pension purposes when it involves other body systems, produces severe symptoms or extensive cavity formation, is a reactivated case, advances on successive examinations, or fails to retrogress after six months of hospitalization.100%
6731Tuberculosis, pulmonary, chronic, inactive. Depending on the findings, residuals are rated as interstitial lung disease, restrictive lung disease, or — when obstructive lung disease is the major residual — as chronic bronchitis (DC 6600). Thoracoplasty is rated as removal of ribs under DC 5297. A mandatory examination is requested immediately after active tuberculosis under DC 6730 is reported inactive.On residuals
6732Pleurisy, tuberculous, active or inactive — rated under §§ 4.88c or 4.89, whichever is appropriate.Rated elsewhere
6701–6724The graduated tuberculosis ratings — far advanced, moderately advanced, minimal and unspecified, active and inactive — apply only where entitlement already existed on August 19, 1968. They are closed to new claims. Tuberculosis diagnosed today runs through DC 6730 and DC 6731 above.Closed to new claims